Skip to content

Weekday Japan business intelligence for finance professionals.

Join the list
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
Company2 articles
Companies

Cuorips Inc.

Latest Tokyo Brief coverage on Cuorips Inc., tracking filings, financial news, and market signals from Japan.

Code
4894
Exchange
TSE
Coverage
2 articles

Latest coverage

TSE:4894

  1. Cuorips' ReHeart Wins Japan Insurance Listing at ¥53.2mn Per Treatment

    Japan's health ministry listed Cuorips' heart-failure therapy ReHeart at ¥53.2mn per treatment for patients who have exhausted standard drug and invasive care, using the cost-calculation pricing method under the new-technology category.

  2. Japan Prices iPS-Derived Heart Patch ReHeart at ¥53.2mn

    Chuikyo, Japan's insurance-pricing panel, set a ¥53.2mn reimbursement price for ReHeart, Cuorips's iPS cell-derived cardiac tissue sheet for severe heart failure, but sales cannot begin until the official listing takes effect on September 1.